Telmisartan Tablet 80 mg (Telmisartan)

Adult dose

For essential hypertension, Telmisartan is administered as 40 mg once daily orally with water. It can be taken regardless of meals. For some patients, 20 mg once daily may be effective, and if necessary, the dosage can be increased to 80 mg once daily. Dose increases should be made after 4-8 weeks of treatment to achieve maximum antihypertensive effect. To reduce the risk of cardiovascular disease, 80 mg once daily is recommended to be taken orally with water and can be taken regardless of meals. The efficacy of lower doses than 80 mg for reducing morbidity and mortality from cardiovascular disease is not known. When initiating treatment for cardiovascular disease risk reduction, monitoring of blood pressure is recommended, and appropriate adjustment of antihypertensive medication may be necessary. ○ For patients with liver impairment Care should be taken when administering to patients with mild to moderate liver impairment, and the dose should not exceed 40 mg once daily.

This drug can cause serious harm to the fetus during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to individuals with hypersensitivity to this drug, pregnant or breastfeeding women, patients with severe liver impairment, a history of angioedema, or certain kidney diseases. Caution is particularly necessary for elderly patients, those with hyperkalemia, liver impairment, or heart and kidney problems when administering this drug. During treatment, regular monitoring of blood pressure, kidney function, and electrolyte levels is essential to detect adverse reactions early and respond appropriately. While this drug lowers blood pressure, side effects such as hypotension, dizziness, kidney function deterioration, hyperkalemia, and angioedema may occur, and immediate consultation with medical personnel is required if symptoms occur. Particularly, if angioedema occurs, careful observation is necessary as it can cause swelling of the face, lips, tongue, and difficulty breathing. This drug may interact with other antihypertensives, diuretics, potassium supplements, and non-steroidal anti-inflammatory drugs, so it should be used in accordance with professional guidance when co-administered. Women who are pregnant or planning to become pregnant should not use this drug, and breastfeeding women should avoid it or discontinue breastfeeding. Safety and efficacy have not been established in children under 18 years of age, so use is not recommended. In case of overdose, symptoms such as hypotension, cardiac arrhythmias, dizziness, and renal failure may occur, so immediate medical attention is necessary. This drug should be stored out of reach of children, and tablets should be opened and used immediately from the sealed state. Caution is needed when driving or operating machinery as dizziness or fainting may occur.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanied respiratory abnormalities, jaundice of skin or eyes, profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significantly decreased urine output

Mild side effects

• Upper respiratory infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• depression

This drug should be stored in a tightly sealed container to avoid exposure to air or humidity. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

White or whitish convex round tablet

Package unit

10 tablets/blister X 3